Amy Wagers

Amy Wagers is a leading stem cell biologist at Harvard whose research on hematopoietic stem cell fate determination and tissue regeneration has informed strategies for optimizing iPSC-derived cell therapy products. Her work on understanding how stem cells age and can be rejuvenated has implications for improving the quality and function of iPSC-derived immune cells for cancer therapy. She has contributed to elucidating the signaling pathways that govern stem cell self-renewal and differentiation relevant to iPSC-based manufacturing.